Placebo News and Research

RSS

Combining clot busters and blood thinners shows no advantage for people with ischemic strokes

Giving blood thinners in addition to clot-busting medications to people with ischemic strokes (clot-caused strokes) did not improve their outcomes 90 days later, according to preliminary late-breaking science presented today at the American Stroke Association's International Stroke Conference 2024.

7 Feb 2024

AMG 133 (maridebart cafraglutide) weight loss drug shows promise in early trial

AMG 133, an engineered bispecific molecule, demonstrated significant weight loss with a favorable safety profile in a phase 1 clinical trial, offering a promising new treatment option for obesity.

7 Feb 2024

AI helps predict antidepressant response in a week

In patients with major depression disorder it is, thanks to use of artificial intelligence, now possible to predict within a week whether an antidepressant will work.

7 Feb 2024

New weight loss drug may be an effective strategy for preventing or treating high blood pressure

The new weight loss medication tirzepatide significantly lowered the systolic blood pressure (the top number in a blood pressure reading) for nearly 500 adults with obesity who took the medication for about eight months, according to new research published today in Hypertension, an American Heart Association journal.

5 Feb 2024

Breakthrough obesity treatments on the horizon, rivaling surgery's success

New obesity pharmacotherapies, including GLP-1 receptor agonists and combinations of entero-pancreatic hormones, show promise in achieving significant weight loss, potentially rivaling bariatric surgery's effectiveness.

4 Feb 2024

Breakthrough gene-editing therapy transforms lives of patients with a hereditary disorder

A group of patients with a hereditary disorder have had their lives transformed by a single treatment of a breakthrough gene-editing therapy, according to the lead researcher.

2 Feb 2024

New trial explores cold-pressed castor oil as safe, natural treatment for dry-eye disease

Researchers at the University of Auckland are running a trial of castor oil as a potential safe and natural treatment for dry-eye disease following a successful pilot study.

2 Feb 2024

Gingko biloba compound injections linked to better stroke outcomes

People with ischemic (clot-caused) stroke had better early recovery of cognitive function if treated with intravenous injections of a combination of biologically active components of ginkgo biloba during the first two weeks after the stroke, according to a preliminary study to be presented at the American Stroke Association's International Stroke Conference 2024.

1 Feb 2024

Cinnamon supplements found to reduce blood glucose in prediabetics

A 12-week study shows that daily cinnamon supplements significantly lower blood glucose levels in obese and overweight prediabetic individuals, suggesting a role for the gut microbiome.

29 Jan 2024

Interventions for mood show promise for the management of IBD in improving mental health, inflammation and disease outcomes

Researchers performed a meta-analysis to explore the impact of mood interventions on inflammatory disease activity in inflammatory bowel disease (IBD).

29 Jan 2024

Immunotherapy drug extends overall survival in kidney cancer patients after surgery

For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer.

27 Jan 2024

Unbiased assessment of vamorolone for treating Duchenne muscular dystrophy

The drug vamorolone (Agamree) has been hailed as a promising new drug to treat Duchenne muscular dystrophy (DMD).

25 Jan 2024

Kiwifruit improves vitality and mood in as little as four days

Kiwifruit has proven itself as a powerful mood booster and new research from the University of Otago has shown just how fast its effects can be.

24 Jan 2024

European consortium awarded €6.5M to study psychedelic-assisted therapy

A European consortium of 19 partners has been awarded over €6.5M by the European Union to study psilocybin to treat psychological distress in people with progressive incurable illnesses requiring palliative care.

24 Jan 2024

Belief in caffeine improves running performance

The placebo effect of caffeine ingestion on running performance.

24 Jan 2024

Is a gluten-free diet always the healthier choice for women?

Study evaluates the impact of gluten-free diets on women's health, revealing benefits for specific gluten-related disorders but cautioning against unnecessary dietary restrictions.

23 Jan 2024

Blood pressure drug could help lower anxiety for kids and young adults with ASD

A new study at the University of Missouri's Thompson Center for Autism and Neurodevelopment found that propranolol, a medication that treats high blood pressure, can also help lower anxiety for kids and young adults with autism spectrum disorder (ASD).

23 Jan 2024

Monoclonal antibodies for Alzheimer's offer little benefit, raise safety concerns

Researchers performed a meta-analysis of randomized trial studies that compared the use of amyloid-reducing monoclonal antibodies (MABs) in patients with Alzheimer's dementia at a dose consistent with that used in Phase 3 or FDA approval trials with the use of a placebo.

22 Jan 2024

Study: Daily multivitamins hold promise for combating cognitive decline

By 2060, according to the Alzheimer’s Association, nearly one in four Americans will be in an age bracket at elevated risk of cognitive decline and Alzheimer’s disease unless interventions can help preserve cognitive function before deficits begin.

22 Jan 2024

New study reveals flaws in AI tools used for SARS-CoV-2 antibody discovery

A discovery program for SARS-CoV-2-nABs potentially targeting its resistant strains.

19 Jan 2024

Placebo News and Research

Combining clot busters and blood thinners shows no advantage for people with ischemic strokes

AMG 133 (maridebart cafraglutide) weight loss drug shows promise in early trial

AI helps predict antidepressant response in a week

New weight loss drug may be an effective strategy for preventing or treating high blood pressure

Breakthrough obesity treatments on the horizon, rivaling surgery's success

Breakthrough gene-editing therapy transforms lives of patients with a hereditary disorder

New trial explores cold-pressed castor oil as safe, natural treatment for dry-eye disease

Gingko biloba compound injections linked to better stroke outcomes

Cinnamon supplements found to reduce blood glucose in prediabetics

Interventions for mood show promise for the management of IBD in improving mental health, inflammation and disease outcomes

Immunotherapy drug extends overall survival in kidney cancer patients after surgery

Unbiased assessment of vamorolone for treating Duchenne muscular dystrophy

Kiwifruit improves vitality and mood in as little as four days

European consortium awarded €6.5M to study psychedelic-assisted therapy

Belief in caffeine improves running performance

Is a gluten-free diet always the healthier choice for women?

Blood pressure drug could help lower anxiety for kids and young adults with ASD

Monoclonal antibodies for Alzheimer's offer little benefit, raise safety concerns

Study: Daily multivitamins hold promise for combating cognitive decline

New study reveals flaws in AI tools used for SARS-CoV-2 antibody discovery

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News